Drug Insight: Adjunctive therapies in adults with bacterial meningitis

Nature Clinical Practice Neurology

Volumn 2, Issue 9, 2006, Pages 504-516

  van de Beek, Diederik ^a,b   Weisfelt, Martijn ^a   de Gans, Jan ^a   Tunkel, Allan R ^c,d   Wijdicks, Eelco F M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Mayo Clinic   (United States)

^c MONMOUTH MEDICAL CENTER   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIOXIDANT; CASPASE INHIBITOR; CORTICOSTEROID; DEXAMETHASONE; DIHYDROERGOTAMINE; EUROPIUM; GLYCEROL; HEPARIN; IMMUNOGLOBULIN; INSULIN; INTERLEUKIN 1BETA ANTIBODY; MANNITOL; MATRIX METALLOPROTEINASE INHIBITOR; MONOCLONAL ANTIBODY; NIMODIPINE; OSMOTIC AGENT; PEROXYNITRITE; PLACEBO; PROSTACYCLIN DERIVATIVE; SODIUM CHLORIDE; STEROID; THIOPENTAL; TUMOR NECROSIS FACTOR ANTIBODY; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERIOLYSIS; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG MEGADOSE; DRUG PENETRATION; HUMAN; INFLAMMATION; INSULIN TREATMENT; INTRACRANIAL HYPERTENSION; MENINGOENCEPHALITIS; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; SUBARACHNOID SPACE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CEREBROSPINAL FLUID SHUNTS; COMBINED MODALITY THERAPY; DIURETICS, OSMOTIC; FLUID THERAPY; HEMATOLOGIC AGENTS; HUMANS; HYPOTHERMIA, INDUCED; MENINGITIS, BACTERIAL;

EID: 33747767883     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0265     Document Type: Review

References (88)

1. van de Beek D et al. (2006) Community-acquired bacterial meningitis in adults. N Engl J Med 354: 44-53
2. van de Beek D et al. (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849-1859
3. Weisfelt M et al. (2006) Clinical features, complications and outcome in adults with pneumococcal meningitis: A prospective series of 352 cases. Lancet Neurol 5: 123-129
4. van de Beek D et al. (2002) Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 186: 1047-1052
5. Weisfelt M et al. (2006) Pneumococcal meningitis in adults: New approaches to management and prevention. Lancet Neurol 5: 332-342
6. van de Beek D and de Gans J (2006) Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 66: 415-427
7. Emonts M et al. (2003) Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3: 565-577
8. Koedel U et al. (2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2: 721-736
9. Kim KS (2003) Pathogenesis of bacterial meningitis: From bacteraemia to neuronal injury. Nat Rev Neurosci 4: 376-385
10. van de Beek D et al. (2003) Corticosteroids for acute bacterial meningitis. The Cochrane Database of Systematic Reviews, Issue 3, Art. No CD004405
11. van der Poll T (2001) Immunotherapy of sepsis. Lancet Infect Dis 1: 165-174
12. Levi M et al. (2004) Bidirectional relation between inflammation and coagulation. Circulation 109: 2698-2704
13. Koedel U et al. (2004) MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 127: 1437-1445
14. Paul R et al. (2004) Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice. J Neuroimmunol 152: 78-82
15. Mitchell L et al. (2004) Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis 190: 2039-2046
16. Bermpohl D et al. (2005) Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115: 1607-1615
17. Hirst RA et al. (2003) Streptococcus pneumoniae damages the ciliated ependyma of the brain during meningitis. Infect Immun 71: 6095-6100
18. Scheld WM et al. (1980) Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis: Alterations with penicillin and methylprednisolone. J Clin Invest 66: 243-253
19. Täuber MG et al. (1985) Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 151: 528-534
20. de Gans J and van de Beek D (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347: 1549-1556
21. van de Beek D and de Gans J (2004) Dexamethasone and pneumococcal meningitis. Ann Intern Med 141: 327
22. Weisfelt M et al. (2006) Dexamethasone in adults with pneumococcal meningitis: Risk factors for death. Eur J Clin Microb Infect Dis 25: 73-78
23. van de Beek D et al. (2004) Steroids in adults with acute bacterial meningitis: A systematic review. Lancet Infect Dis 4: 139-143
24. Cooper MS and Stewart PM (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348: 727-734
25. Annane D et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871
26. Leib SL et al. (2003) Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 54: 353-357
27. Alejandria MM et al. (2002) Intravenous immunoglobulin for treating sepsis and septic shock. The Cochrane Database of Systematic Reviews, Issue 1, Art. No CD001090
28. Gigliotti F et al. (1987) IgG penetration into the cerebrospinal fluid in a rabbit model of meningitis. J Infect Dis 156: 394-398
29. Wippl G (1977) Therapy of purulent meningitis with immunoglobulins [German]. Padiatr Padol 12: 309-312
30. Noack R et al. (1987) Immunoglobulins in the treatment of bacterial meningitis in childhood [German]. Infection 15: 11-15
31. Neu IS and Pelka RB (1982) Immunoglobulins in bacterial and viral meningitis: Results of a controlled randomized clinical study of intravenous and intrathecal application [German]. Forschr Med 17: 802-809
32. Kastenbauer S and Pfister HW (2003) Pneumococcal meningitis in adults - spectrum of complications and prognostic factors in a series of 87 cases. Brain 126: 1015-1025
33. Bernard GR et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709
34. Abraham E et al. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353: 1332-1341
35. Vincent JL et al. (2005) Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: A retrospective analysis of patients enrolled in recent clinical studies. Crit Care 9: R331-R343
36. Haring HP et al. (1993) Time course of cerebral blood flow velocity in central nervous system infections: A transcranial Doppler sonography study. Arch Neurol 50: 98-101
37. Winkler J et al. (1994) Surgical intervention and heparin-anticoagulation improve prognosis of rhinogenic/otogenic and posttraumatic meningitis. Acta Neurol Scand 89: 293-298
38. MacFarlane JT et al. (1977) Failure of heparin to alter the outcome of pneumococcal meningitis. BMJ 2: 1522
39. Weber JR et al. (1977) Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis. J Cereb Blood Flow Metab 17: 1221-1229
40. Stam J et al. (2002) Anticoagulation for cerebral sinus thrombosis. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD002005
41. Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352: 1791-1798
42. Winkler F et al. (2002) Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology 59: 1350-1355
43. Hermans PW et al. (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 354: 556-560
44. Roos YB et al. (2001) Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32: 1860-1862
45. Hosoglu S et al. (1997) Effects of nimodipine on the cerebrovascular and neuronal changes during pneumococcal meningitis in the rat. Acta Microbiol Immunol Hung 44: 271-279
46. Paul R et al. (2000) Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis. Crit Care Med 28: 2552-2556
47. Unterberg AW et al. (2004) Edema and brain trauma. Neuroscience 129: 1021-1029
48. Wijdicks EF and Diringer MN (1998) Middle cerebral artery territory infarction and early brain swelling: Progression and effect of age on outcome. Mayo Clin Proc 73: 829-836
49. Muizelaar JP et al. (1991) Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. J Neurosurg 75: 731-739
50. Moller K et al. (2000) Effect of short-term hyperventilation on cerebral blood flow autoregulation in patients with acute bacterial meningitis. Stroke 31: 1116-1122
51. Moller K et al. (2002) Cerebral blood flow, oxidative metabolism and cerebrovascular carbon dioxide reactivity in patients with acute bacterial meningitis. Acta Anaesthesiol Scand 46: 567-578
52. Muizelaar JP et al. (1983) Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 59: 822-828
53. Burke A et al. (1981) The effects of mannitol on blood viscosity. J Neurosurg 55: 550-553
54. Schrot RJ and Muizelaar JP (2002) Mannitol in acute traumatic brain injury. Lancet 359: 1633-1634
55. Syrogiannopoulos GA et al. (1987) Mannitol treatment in experimental Haemophilus influenzae type b meningitis. Pediatr Res 22: 118-122
56. Lorenzl S et al. (1996) Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Crit Care Med 24: 1874-1880
57. Kilpi T et al. (1995) Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatr Infect Dis J 14: 270-278
58. Choi CW et al. (2005) Effects of hypertonic (7%) saline on brain injury in experimental Escherichia coli meningitis. J Korean Med Sci 20: 870-876
59. Lindvall P et al. (2004) Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 38: 384-390
60. Cooke RS and Patterson V (1999) Acute obstructive hydrocephalus complicating bacterial meningitis: Hydrocephalus was probably non-obstructive. BMJ 318: 124
61. Wang KW et al. (2005) Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol 64: 61-65
62. Mactier H et al. (1998) Acute obstructive hydrocephalus complicating bacterial meningitis in childhood. BMJ 316: 1887-1889
63. Hypothermia after Cardiac Arrest Study Group (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346: 549-556
64. Bernard SA et al. (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 348: 557-563
65. Shankaran S et al. (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353: 1574-1584
66. Olsen TS et al. (2003) Therapeutic hypothermia for acute stroke. Lancet Neurol 2: 410-416
67. McIntyre LA et al. (2003) Prolonged therapeutic hypothermia after traumatic brain injury in adults: A systematic review. JAMA 289: 2992-2999
68. Wijdicks EF (2004) Induced hypothermia in neurocatastrophes: Feeling the chill. Rev Neurol Dis 1: 10-15
69. Angstwurm K et al. (2000) Induced hypothermia in experimental pneumococcal meningitis. J Cereb Blood Flow Metab 20: 834-838
70. Deng H et al. (2003) Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation. Stroke 34: 2495-2501
71. Harrigan MR (1996) Cerebral salt wasting syndrome: A review. Neurosurgery 38: 152-160
72. Oates-Whitehead R et al. (2005) Fluid therapy for acute bacterial meningitis. The Cochrane Database of Systematic Reviews, Issue 3, Art. No CD004786
73. Täuber MG et al. (1993) Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis. J Infect Dis 168: 473-476
74. Begg N et al. (1999) Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect 39: 1-15
75. Marik PE and Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30: 748-756
76. Hansen TK et al. (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88: 1082-1088
77. Van den Berghe G et al. (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461
78. Ivey NS et al. (2005) A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat. J Neurosci Methods 142: 91-95
79. Angstwurm K et al. (2004) Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis. Infect Immun 72: 3294-3298
80. Kastenbauer S et al. (2004) Protective role of NF-κB1 (p50) in experimental pneumococcal meningitis. Eur J Pharmacol 498: 315-318
81. Bottcher T et al. (2004) Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. J Neurochem 91: 1450-1460
82. Saukkonen K et al. (1990) The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 171: 439-448
83. Leib SL et al. (2001) Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124: 1734-1742
84. Kastenbauer S (2006) Pneumococcal meningitis: A 21st century perspective. Lancet Neurol 5: 104-105
85. Klein M et al. (2003) Meningitis-associated hearing loss: Protection by adjunctive antioxidant therapy. Ann Neurol 54: 451-458
86. Koedel U et al. (2002) Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 22: 39-49
87. Koedel U et al. (2002) Role of caspase-1 in experimental pneumococcal meningitis: Evidence from pharmacologic caspase inhibition and caspase-1-deficient mice. Ann Neurol 51: 319-329
88. Braun JS et al. (1999) Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nature Med 5: 298-302